Hormone therapy is often recommended for DCIS and Stage 1A invasive breast cancer if the tumors are hormone receptor-positive (ER or PR). Here are some key points:

- Hormone Receptor-Positive Tumors: If your cancer cells have estrogen or progesterone receptors, hormone therapy can help reduce the risk of recurrence
- Show Full Answer

Hormone therapy is often recommended for DCIS and Stage 1A invasive breast cancer if the tumors are hormone receptor-positive (ER or PR). Here are some key points:

- Hormone Receptor-Positive Tumors: If your cancer cells have estrogen or progesterone receptors, hormone therapy can help reduce the risk of recurrence.
- Common Hormone Therapies: Tamoxifen is a common hormone therapy that blocks these receptors.
- Duration: Typically taken for five years after surgery.
- Risks: Hormone therapies can increase the risk of uterine cancer and decrease bone density, so regular pelvic exams and bone density tests are recommended.

If you have concerns, discuss them with your healthcare team to weigh the benefits and risks specific to your situation.

 This AI-generated response comes from MyBCTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Stage 0 Breast Cancer: Treatment and Prognosis | MyBCTeam

Ductal Carcinoma In Situ (DCIS): Your Guide | MyBCTeam